ETON PHARMACEUTICALS

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

25 11 2024 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

12 11 2024 16:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)

07 11 2024 07:00:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

06 11 2024 16:30:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

03 10 2024 06:30:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

22 8 2024 16:30:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

08 8 2024 16:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

30 7 2024 17:30:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

15 7 2024 16:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

09 5 2024 16:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

01 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

30 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

29 4 2024 16:30:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

22 3 2024 02:00:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

14 3 2024 16:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024

29 2 2024 16:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation

21 2 2024 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules

02 2 2024 06:50:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results

09 11 2023 16:01:00 提供 Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

30 10 2023 06:50:00 提供 Nasdaq GlobeNewswire